Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Depreciation and Depletion (2020 - 2024)

KORU Medical Systems (KRMD) has disclosed Depreciation and Depletion for 5 consecutive years, with $227785.0 as the latest value for Q3 2024.

  • On a quarterly basis, Depreciation and Depletion rose 13.96% to $227785.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $876898.0, a 14.69% increase, with the full-year FY2014 number at $225613.0, up 20.96% from a year prior.
  • Depreciation and Depletion was $227785.0 for Q3 2024 at KORU Medical Systems, down from $234323.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $234323.0 in Q2 2024 to a low of $72768.0 in Q1 2020.
  • A 5-year average of $146581.3 and a median of $110478.0 in 2022 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: decreased 6.29% in 2022, then surged 109.63% in 2023.
  • KORU Medical Systems' Depreciation and Depletion stood at $99071.0 in 2020, then grew by 1.44% to $100502.0 in 2021, then skyrocketed by 53.78% to $154553.0 in 2022, then rose by 29.33% to $199880.0 in 2023, then grew by 13.96% to $227785.0 in 2024.
  • Per Business Quant, the three most recent readings for KRMD's Depreciation and Depletion are $227785.0 (Q3 2024), $234323.0 (Q2 2024), and $214910.0 (Q1 2024).